TY - JOUR T1 - Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.220213 SP - jrheum.220213 AU - Corrado Campochiaro AU - Nicola Farina AU - Giacomo De Luca AU - Giorgia Trignani AU - Alessandro Tomelleri AU - Marco Matucci-Cerinic AU - Lorenzo Dagna Y1 - 2022/09/15 UR - http://www.jrheum.org/content/early/2022/09/11/jrheum.220213.abstract N2 - Antisynthetase syndrome (AS) is a rare autoimmune disorder whose treatment remains a challenge.1 In refractory cases, treatment escalation from glucocorticoids (GCs) and immunosuppressants to rituximab (RTX) is recommended.1 ER -